Katrin Groebke Zbinden

This inventor holds 54 USPTO granted patents and 33 published patent applications, plus 3 CIPO patents and 32 EPO patents, primarily in Heterocyclic Compounds (CPC class C07D). Top assignee: Hoffmann-La Roche Inc.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katrin Groebke Zbinden. Retrieved from https://idiyas.com/inventor/katrin-groebke-zbinden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 54 (Patent Applications = 33)

% Patents Active = 31.5

CIPO Patents = 3 (Patent Applications = 12)

EPO Patents = 32 (Patent Applications = 52)

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 97(Granted Patents)

Forward Citations (Not Self Cited) = 78(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Basel, CH (2003 - 2023)
Liestal, CH (2008 - 2023)
Oberwil BL, CH (2023)

Company Filing History:

54 out of 5,024

Hoffmann-La Roche Inc.

patents

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

GABA Modulators

CNS Disorders

PDE10 Inhibitors

Triazolopyridine

Benzamides

Imidazole Derivatives

Nitrogen-Containing Compounds

Isoxazolyl Derivatives

TAAR1 Ligands

Pyrrolopyridine

Substituted Imidazoles

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747235 - Triazolyl derivatives as GABAα5 PAM (2026-09-29),

2. 12577257 - Heterocyclic compounds (2026-03-17),

3. 12509467 - CGAS inhibiting triazolopyrimidone derivatives (2025-12-30),

4. 12281124 - Heterocyclic compounds as monoacylglycerol lipase inhibitors (2025-04-21),

5. 11840528 - Isoxazolyl ether derivatives as GABAα5 PAM (2023-12-12),

6. 11814375 - Heterocyclic compounds (2023-11-14),

7. 11802133 - Heterocyclic compounds as monoacylglycerol lipase inhibitors (2023-10-31),

8. 11697636 - Substituted benzamides (2023-07-11),

9. 11091471 - Isoxazolyl ether derivatives as GABAα5 PAM (2021-08-17),

10. 10501411 - Substituted benzamides (2019-12-10),

11. 10399985 - (Hetero)aryl imidazoles/pyrazoles for treatment of neurological disorders (2019-09-03),

12. 9932335 - Pyrrolopyridine or pyrazolopyridine derivatives (2018-04-03),

13. 9708302 - Flouro-naphthyl derivatives (2017-07-18),

14. 9708259 - Indol and indazol derivatives (2017-07-18),

15. 9617271 - Triazolo compounds (2017-04-11),

Title: The Innovative Journey of Katrin Groebke Zbinden

Introduction:

Katrin Groebke Zbinden is a pioneering inventor hailing from Liestal, Switzerland. Her remarkable contributions to the field of innovation have left a lasting impact on various industries.

Latest Patents:

Katrin Groebke Zbinden's latest patents showcase her dedication to pushing the boundaries of technology and creativity. Her inventions continue to shape the landscape of innovation in Switzerland and beyond.

Career Highlights:

Throughout her illustrious career, Katrin Groebke Zbinden has demonstrated a keen ability to transform ideas into tangible inventions. Her innovative spirit and relentless pursuit of excellence have earned her recognition as a trailblazer in the world of inventors.

Collaborations:

Katrin Groebke Zbinden has collaborated with leading experts and organizations to bring her inventions to life. Her partnerships have been instrumental in driving forward groundbreaking projects and fostering a culture of innovation.

Conclusion:

In conclusion, Katrin Groebke Zbinden's journey as an inventor exemplifies the power of creativity, perseverance, and collaboration in driving meaningful change. Her legacy will continue to inspire future generations of innovators to dream big and push the boundaries of what is possible.

Profile summary based on public USPTO records.